Welcome to Novartis Investor Relations for the United States. Novartis (NYSE: NVS), which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader in the research and development of products that protect and improve health and well-being. Its core businesses are in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.
US Investor Center
Information for investors on buying ADSs through Direct Purchase, material information on ADS proxy voting and Syngenta tax basis information.
